Skip to content
healthcare.dev

equate mucus d

NDC 79903-125, guaifenesin and pseudoephedrine hydrochloride, tablet, multilayer, extended release, from WALMART INC..

Product NDC
79903-125
Status
Listed
Labeler
WALMART INC.
Dosage form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA214407
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/79903-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
79903-125-36799030125362 BLISTER PACK in 1 CARTON (79903-125-36) / 18 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 79903-125 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/79903-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 79903-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.